Under the interim order with respect to the importation and sale of medical devices for use in relation to COVID-19, a post-market authorization condition is placed on every serological test approved for use in Canada. There are two approved tests for use in Canada. The requirement of the order that the minister signed is that two weeks after approval, companies have to start providing information—data and evidence—on their use in Canada.
Does the minister have that information and can she share it with this committee?